Use cases
Put the data to work
External control arms, safety studies, HTA submissions, treatment patterns. Each states the regulatory expectation, the variables it needs and what Hilbi supplies today.
- In the buyer's vocabulary
- Regulatory expectation stated
- What is available today
External control arms
built from routine care
PASS and HTA
resource use as recorded
One page per use case
The regulatory expectation, the variables required, what is available today.
External control arm
The cohort characteristics that make a dataset usable as a comparator, and the variables a regulator expects.
Post-authorisation safety study
Longitudinal capture, outcome coding and the latency a PASS protocol can accept.
HTA and market-access submission
Treatment patterns, burden of illness and the completeness a submission has to defend.
Treatment patterns and burden of illness
What was done, in what order, at what interval. As recorded, not as recalled.
What Hilbi supplies today
What a sponsor receives for each use case, and what stays out of scope.
| Use case | What Hilbi supplies | What stays out of scope |
|---|---|---|
| External control arm | Anonymised longitudinal pathway data with the treatment sequence and the interval between steps | Patient identity, and any combination that would re-identify |
| Post-authorisation safety study | Scheduled and completed steps, discontinuation intervals, and the reason recorded at the step | Adverse event adjudication, which stays with the sponsor's pharmacovigilance |
| Health technology assessment | Resource use recorded during care: visits, tests, procedures and waits | Pricing and reimbursement negotiation |
| Feasibility | Cohort size, completeness per variable and latency, for the indication and the market | Site contracting, which runs separately |
Monthly briefing
The signal, once a month.
What changed in European health data, what we shipped, and what it means for a provider. Nothing else.